Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2011
Reporting Period: Three months ended March 31, 2011
This filing announces the issuance of a press release and a subsequent conference call regarding the Company's financial results for the quarter ended March 31, 2011.
Key Financial Metrics
The Form 8-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) and conference call transcript (Exhibit 99.2), which are incorporated by reference but not detailed in the body of this filing.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text provided. It serves as a notification that such results have been announced via external exhibits.
Guidance, Outlook, and Risks
Management Commentary: The Company held a public telephone conference call to discuss financial results and related matters.
Legal Disclaimer: The information in Item 2.02 and the attached exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, except as expressly set forth by specific reference in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and earnings per share figures for the quarter ended March 31, 2011.
- Review Exhibit 99.2 (Conference Call Transcript) for management's commentary on operational trends and future outlook.
- Verify if the press release includes updated financial guidance or forward-looking statements.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the referenced exhibits.